CN103080743B - 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 - Google Patents

用于肾损伤和肾衰竭的诊断及预后的方法和组合物 Download PDF

Info

Publication number
CN103080743B
CN103080743B CN201180038804.5A CN201180038804A CN103080743B CN 103080743 B CN103080743 B CN 103080743B CN 201180038804 A CN201180038804 A CN 201180038804A CN 103080743 B CN103080743 B CN 103080743B
Authority
CN
China
Prior art keywords
hours
experimenter
purposes according
serum creatinine
body fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180038804.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN103080743A (zh
Inventor
J·安德伯格
J·格雷
P·麦克弗森
K·中村
J·P·坎普夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astute Medical Inc
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Priority to CN201510428093.2A priority Critical patent/CN105137085A/zh
Publication of CN103080743A publication Critical patent/CN103080743A/zh
Application granted granted Critical
Publication of CN103080743B publication Critical patent/CN103080743B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4725—Mucins, e.g. human intestinal mucin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4745—Insulin-like growth factor binding protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/521—Chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5431—IL-11
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G01N2333/7155—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201180038804.5A 2010-06-23 2011-06-23 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 Expired - Fee Related CN103080743B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510428093.2A CN105137085A (zh) 2010-06-23 2011-06-23 用于肾损伤和肾衰竭的诊断及预后的方法和组合物

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US35796510P 2010-06-23 2010-06-23
US35795610P 2010-06-23 2010-06-23
US61/357,956 2010-06-23
US61/357,965 2010-06-23
US36430410P 2010-07-14 2010-07-14
US36430010P 2010-07-14 2010-07-14
US61/364,304 2010-07-14
US61/364,300 2010-07-14
PCT/US2011/001127 WO2011162820A1 (en) 2010-06-23 2011-06-23 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510428093.2A Division CN105137085A (zh) 2010-06-23 2011-06-23 用于肾损伤和肾衰竭的诊断及预后的方法和组合物

Publications (2)

Publication Number Publication Date
CN103080743A CN103080743A (zh) 2013-05-01
CN103080743B true CN103080743B (zh) 2015-07-22

Family

ID=45371738

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201510428093.2A Pending CN105137085A (zh) 2010-06-23 2011-06-23 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN201180038804.5A Expired - Fee Related CN103080743B (zh) 2010-06-23 2011-06-23 用于肾损伤和肾衰竭的诊断及预后的方法和组合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201510428093.2A Pending CN105137085A (zh) 2010-06-23 2011-06-23 用于肾损伤和肾衰竭的诊断及预后的方法和组合物

Country Status (11)

Country Link
US (2) US20130165344A1 (enExample)
EP (3) EP3489688A1 (enExample)
JP (2) JP2013531240A (enExample)
CN (2) CN105137085A (enExample)
AU (1) AU2011269774B2 (enExample)
CA (1) CA2803500A1 (enExample)
EA (1) EA201291314A1 (enExample)
HK (1) HK1212770A1 (enExample)
MX (1) MX2013000220A (enExample)
NZ (1) NZ606124A (enExample)
WO (1) WO2011162820A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2585827A4 (en) 2010-06-23 2013-12-04 Astute Medical Inc METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
US20130330829A1 (en) * 2012-06-06 2013-12-12 The Cleveland Clinic Foundation Prediction of acute kidney injury from a post-surgical metabolic blood panel
WO2016048388A1 (en) 2014-09-26 2016-03-31 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
EA201790696A1 (ru) * 2014-10-20 2017-10-31 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности
WO2016083374A1 (en) * 2014-11-25 2016-06-02 F. Hoffmann-La Roche Ag Biomarkers of fast progression of chronic kidney disease
EP3294416A4 (en) * 2015-05-12 2018-11-21 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA3049444A1 (en) 2017-01-12 2018-07-19 Astute Medical, Inc. Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement
GB201703313D0 (en) * 2017-03-01 2017-04-12 Mologic Ltd Urinary tract infection diagnostic
JP7604376B2 (ja) 2018-12-28 2024-12-23 バーテックス ファーマシューティカルズ インコーポレイテッド 改変ウロキナーゼ型プラスミノゲンアクティベータポリペプチドおよび使用方法
EP4138550A1 (en) * 2020-04-21 2023-03-01 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cxcl13 gene
CN113552369B (zh) * 2021-07-23 2023-10-20 江苏省中医院 蛋白标志物联合用于2型糖尿病、2型糖尿病肾病的诊断的用途
KR20250068980A (ko) * 2023-11-10 2025-05-19 계명대학교 산학협력단 당뇨병성 신경병증 조기 진단용 바이오마커 조성물

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
FI922164L (fi) 1990-09-14 1992-05-13 Biosite Diagnostics Inc Antikroppar mot komplex av ligandreceptorer och ligander och anvaendningen daerav vid bestaemning av ligandreceptorer.
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
WO1992018866A1 (en) 1991-04-10 1992-10-29 Biosite Diagnostics Incorporated Novel conjugates and assays for simultaneous detection of multiple ligands
EP0585310B1 (en) 1991-04-10 1999-03-17 Biosite Diagnostics Inc. Crosstalk inhibitors and their uses
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
CN1374525A (zh) * 2001-12-31 2002-10-16 陕西超英生物医学研究开发有限公司 一种抗体芯片、其制备技术及其检测方法
CN1871517A (zh) * 2002-02-19 2006-11-29 免疫公司 快速有效分离循环癌细胞的方法和试剂
MXPA05010385A (es) * 2003-03-27 2006-03-08 Childrens Hosp Medical Center Metodo y estuche para detectar el inicio temprano de lesion celular tubular renal.
US20060134708A1 (en) * 2004-10-14 2006-06-22 Northwestern University Detection and treatment of renal cancer
EP2604703B1 (en) * 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Methods for evaluating graft survival in a solid organ transplant recipient
CN101358976A (zh) * 2008-04-28 2009-02-04 北京华大吉比爱生物技术有限公司 检测六项肿瘤标志物的微阵列-酶联免疫检测试剂盒
CN104330574B (zh) * 2008-11-10 2017-04-12 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
EP2364370B1 (en) * 2008-11-22 2014-09-03 Astute Medical, Inc. Methods for prognosis of acute renal failure
CN101735317A (zh) * 2008-11-25 2010-06-16 中国科学院北京基因组研究所 Cathepsin D抗原多肽、应用及含有该多肽的检测试剂盒
JP5775874B2 (ja) * 2009-08-28 2015-09-09 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
ES2818138T3 (es) * 2009-12-20 2021-04-09 Astute Medical Inc Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
CN102539745B (zh) * 2010-12-31 2013-03-06 中国人民解放军第三〇九医院 移植肾排斥反应早期诊断及预警试剂盒
KR101325928B1 (ko) * 2013-01-14 2013-11-07 이명재 설치가 간편한 논 물꼬용 패널

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Endothelial and Epithelial Expression of Eotaxin-2 (CCL24) in Nasal Polyps;Schaefer等;《int. arch allergy immunol.》;20060508;第140卷(第3期);第205－214页 *

Also Published As

Publication number Publication date
AU2011269774A1 (en) 2013-02-07
NZ606124A (en) 2015-05-29
WO2011162820A1 (en) 2011-12-29
US20130165344A1 (en) 2013-06-27
HK1212770A1 (zh) 2016-06-17
CN105137085A (zh) 2015-12-09
EP2585826A1 (en) 2013-05-01
EP3489688A1 (en) 2019-05-29
JP2013531240A (ja) 2013-08-01
EP2899545A1 (en) 2015-07-29
EA201291314A1 (ru) 2013-11-29
JP2016136154A (ja) 2016-07-28
HK1179344A1 (en) 2013-09-27
EP2899545B1 (en) 2018-08-22
CA2803500A1 (en) 2011-12-29
CN103080743A (zh) 2013-05-01
AU2011269774B2 (en) 2015-07-30
US20170254816A1 (en) 2017-09-07
MX2013000220A (es) 2013-03-22
EP2585826A4 (en) 2013-12-04

Similar Documents

Publication Publication Date Title
CN105074466B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN103874923B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN102791885B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN102725636B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN102439441B (zh) 用于肾损伤和肾衰竭的诊断及预后方法和组合物
CN102792161B (zh) 肾损伤和肾衰竭的诊断及预后的方法及组合物
US10823742B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP7217796B2 (ja) 腎障害および腎不全の診断および予後のための方法および組成物
CN103080743B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN102369293B (zh) 肾损伤和肾衰竭的诊断及预后
CN102711827B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN102576011B (zh) 用于肾损伤和肾衰竭的诊断及预后的组合物和方法
CN102597258B (zh) 肾损伤和肾衰竭的诊断及预后
CN103238068B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN102725635B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN103858008B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
US20130210043A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102576012B (zh) 用于肾损伤和肾衰竭的诊断及预后方法和组合物
CN102884205B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN107003325A (zh) 用于诊断和预后肾损伤和肾衰竭的方法和组合物
CN104379758A (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN104335045B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN104583774A (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN105209914B (zh) 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN107709993A (zh) 用于肾损伤和肾衰竭的诊断和预后的方法和组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1179344

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1179344

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150722

Termination date: 20200623